Report Detail

Request for Sample of this report

Pharma & Healthcare Global Emphysema Treatment Medication Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4611652
    • |
  • 02 September, 2024
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
According to our (Global Info Research) latest study, the global Emphysema Treatment Medication market size was valued at US$ 4244 million in 2023 and is forecast to a readjusted size of USD 5304 million by 2030 with a CAGR of 3.2% during review period.
Surge in prevalence of emphysema and rise in number of smokers are expected to drive the growth of the emphysema treatment market. For instance, according to 2024 article by American Lung Association, it was estimated that over 3 million people in the U.S. have been diagnosed with emphysema. Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.
This report is a detailed and comprehensive analysis for global Emphysema Treatment Medication market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Emphysema Treatment Medication market size and forecasts, in consumption value ($ Million), 2019-2030
Global Emphysema Treatment Medication market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Emphysema Treatment Medication market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Emphysema Treatment Medication market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Emphysema Treatment Medication
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Emphysema Treatment Medication market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emphasys Medical, Pfizer, Uptake Medical, Inogen, Inc, Viatris Inc, Boehringer Ingelheim International GmbH, Novartis AG, AstraZeneca, Orion Corporation, Teva Pharmaceutical Industries Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Emphysema Treatment Medication market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Emphysema Treatment Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bronchodilators
Steroids
Others
Market segment by Application
Hospitals
Homecare
Others
Market segment by players, this report covers
Emphasys Medical
Pfizer
Uptake Medical
Inogen, Inc
Viatris Inc
Boehringer Ingelheim International GmbH
Novartis AG
AstraZeneca
Orion Corporation
Teva Pharmaceutical Industries Ltd
Verona Pharma Plc
GlaxoSmithKline Plc
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Emphysema Treatment Medication product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Emphysema Treatment Medication, with revenue, gross margin, and global market share of Emphysema Treatment Medication from 2019 to 2024.
Chapter 3, the Emphysema Treatment Medication competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Emphysema Treatment Medication market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Emphysema Treatment Medication.
Chapter 13, to describe Emphysema Treatment Medication research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Emphysema Treatment Medication by Type
    • 1.3.1 Overview: Global Emphysema Treatment Medication Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Emphysema Treatment Medication Consumption Value Market Share by Type in 2023
    • 1.3.3 Bronchodilators
    • 1.3.4 Steroids
    • 1.3.5 Others
  • 1.4 Global Emphysema Treatment Medication Market by Application
    • 1.4.1 Overview: Global Emphysema Treatment Medication Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Homecare
    • 1.4.4 Others
  • 1.5 Global Emphysema Treatment Medication Market Size & Forecast
  • 1.6 Global Emphysema Treatment Medication Market Size and Forecast by Region
    • 1.6.1 Global Emphysema Treatment Medication Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Emphysema Treatment Medication Market Size by Region, (2019-2030)
    • 1.6.3 North America Emphysema Treatment Medication Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Emphysema Treatment Medication Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Emphysema Treatment Medication Market Size and Prospect (2019-2030)
    • 1.6.6 South America Emphysema Treatment Medication Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Emphysema Treatment Medication Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Emphasys Medical
    • 2.1.1 Emphasys Medical Details
    • 2.1.2 Emphasys Medical Major Business
    • 2.1.3 Emphasys Medical Emphysema Treatment Medication Product and Solutions
    • 2.1.4 Emphasys Medical Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Emphasys Medical Recent Developments and Future Plans
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Emphysema Treatment Medication Product and Solutions
    • 2.2.4 Pfizer Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Pfizer Recent Developments and Future Plans
  • 2.3 Uptake Medical
    • 2.3.1 Uptake Medical Details
    • 2.3.2 Uptake Medical Major Business
    • 2.3.3 Uptake Medical Emphysema Treatment Medication Product and Solutions
    • 2.3.4 Uptake Medical Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Uptake Medical Recent Developments and Future Plans
  • 2.4 Inogen, Inc
    • 2.4.1 Inogen, Inc Details
    • 2.4.2 Inogen, Inc Major Business
    • 2.4.3 Inogen, Inc Emphysema Treatment Medication Product and Solutions
    • 2.4.4 Inogen, Inc Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Inogen, Inc Recent Developments and Future Plans
  • 2.5 Viatris Inc
    • 2.5.1 Viatris Inc Details
    • 2.5.2 Viatris Inc Major Business
    • 2.5.3 Viatris Inc Emphysema Treatment Medication Product and Solutions
    • 2.5.4 Viatris Inc Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Viatris Inc Recent Developments and Future Plans
  • 2.6 Boehringer Ingelheim International GmbH
    • 2.6.1 Boehringer Ingelheim International GmbH Details
    • 2.6.2 Boehringer Ingelheim International GmbH Major Business
    • 2.6.3 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Product and Solutions
    • 2.6.4 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
  • 2.7 Novartis AG
    • 2.7.1 Novartis AG Details
    • 2.7.2 Novartis AG Major Business
    • 2.7.3 Novartis AG Emphysema Treatment Medication Product and Solutions
    • 2.7.4 Novartis AG Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Novartis AG Recent Developments and Future Plans
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Emphysema Treatment Medication Product and Solutions
    • 2.8.4 AstraZeneca Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 AstraZeneca Recent Developments and Future Plans
  • 2.9 Orion Corporation
    • 2.9.1 Orion Corporation Details
    • 2.9.2 Orion Corporation Major Business
    • 2.9.3 Orion Corporation Emphysema Treatment Medication Product and Solutions
    • 2.9.4 Orion Corporation Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Orion Corporation Recent Developments and Future Plans
  • 2.10 Teva Pharmaceutical Industries Ltd
    • 2.10.1 Teva Pharmaceutical Industries Ltd Details
    • 2.10.2 Teva Pharmaceutical Industries Ltd Major Business
    • 2.10.3 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Product and Solutions
    • 2.10.4 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
  • 2.11 Verona Pharma Plc
    • 2.11.1 Verona Pharma Plc Details
    • 2.11.2 Verona Pharma Plc Major Business
    • 2.11.3 Verona Pharma Plc Emphysema Treatment Medication Product and Solutions
    • 2.11.4 Verona Pharma Plc Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Verona Pharma Plc Recent Developments and Future Plans
  • 2.12 GlaxoSmithKline Plc
    • 2.12.1 GlaxoSmithKline Plc Details
    • 2.12.2 GlaxoSmithKline Plc Major Business
    • 2.12.3 GlaxoSmithKline Plc Emphysema Treatment Medication Product and Solutions
    • 2.12.4 GlaxoSmithKline Plc Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 GlaxoSmithKline Plc Recent Developments and Future Plans
  • 2.13 Pulmonx
    • 2.13.1 Pulmonx Details
    • 2.13.2 Pulmonx Major Business
    • 2.13.3 Pulmonx Emphysema Treatment Medication Product and Solutions
    • 2.13.4 Pulmonx Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Pulmonx Recent Developments and Future Plans
  • 2.14 Bioxyne
    • 2.14.1 Bioxyne Details
    • 2.14.2 Bioxyne Major Business
    • 2.14.3 Bioxyne Emphysema Treatment Medication Product and Solutions
    • 2.14.4 Bioxyne Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Bioxyne Recent Developments and Future Plans
  • 2.15 Intrexon
    • 2.15.1 Intrexon Details
    • 2.15.2 Intrexon Major Business
    • 2.15.3 Intrexon Emphysema Treatment Medication Product and Solutions
    • 2.15.4 Intrexon Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Intrexon Recent Developments and Future Plans
  • 2.16 Icure Pharmaceuticals
    • 2.16.1 Icure Pharmaceuticals Details
    • 2.16.2 Icure Pharmaceuticals Major Business
    • 2.16.3 Icure Pharmaceuticals Emphysema Treatment Medication Product and Solutions
    • 2.16.4 Icure Pharmaceuticals Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Icure Pharmaceuticals Recent Developments and Future Plans
  • 2.17 Kamada
    • 2.17.1 Kamada Details
    • 2.17.2 Kamada Major Business
    • 2.17.3 Kamada Emphysema Treatment Medication Product and Solutions
    • 2.17.4 Kamada Emphysema Treatment Medication Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Kamada Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Emphysema Treatment Medication Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Emphysema Treatment Medication by Company Revenue
    • 3.2.2 Top 3 Emphysema Treatment Medication Players Market Share in 2023
    • 3.2.3 Top 6 Emphysema Treatment Medication Players Market Share in 2023
  • 3.3 Emphysema Treatment Medication Market: Overall Company Footprint Analysis
    • 3.3.1 Emphysema Treatment Medication Market: Region Footprint
    • 3.3.2 Emphysema Treatment Medication Market: Company Product Type Footprint
    • 3.3.3 Emphysema Treatment Medication Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Emphysema Treatment Medication Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Emphysema Treatment Medication Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Emphysema Treatment Medication Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Emphysema Treatment Medication Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Emphysema Treatment Medication Consumption Value by Type (2019-2030)
  • 6.2 North America Emphysema Treatment Medication Market Size by Application (2019-2030)
  • 6.3 North America Emphysema Treatment Medication Market Size by Country
    • 6.3.1 North America Emphysema Treatment Medication Consumption Value by Country (2019-2030)
    • 6.3.2 United States Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Emphysema Treatment Medication Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Emphysema Treatment Medication Consumption Value by Type (2019-2030)
  • 7.2 Europe Emphysema Treatment Medication Consumption Value by Application (2019-2030)
  • 7.3 Europe Emphysema Treatment Medication Market Size by Country
    • 7.3.1 Europe Emphysema Treatment Medication Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 7.3.3 France Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Emphysema Treatment Medication Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Emphysema Treatment Medication Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Emphysema Treatment Medication Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Emphysema Treatment Medication Market Size by Region
    • 8.3.1 Asia-Pacific Emphysema Treatment Medication Consumption Value by Region (2019-2030)
    • 8.3.2 China Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 8.3.5 India Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Emphysema Treatment Medication Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Emphysema Treatment Medication Consumption Value by Type (2019-2030)
  • 9.2 South America Emphysema Treatment Medication Consumption Value by Application (2019-2030)
  • 9.3 South America Emphysema Treatment Medication Market Size by Country
    • 9.3.1 South America Emphysema Treatment Medication Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Emphysema Treatment Medication Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Emphysema Treatment Medication Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Emphysema Treatment Medication Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Emphysema Treatment Medication Market Size by Country
    • 10.3.1 Middle East & Africa Emphysema Treatment Medication Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Emphysema Treatment Medication Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Emphysema Treatment Medication Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Emphysema Treatment Medication Market Drivers
  • 11.2 Emphysema Treatment Medication Market Restraints
  • 11.3 Emphysema Treatment Medication Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Emphysema Treatment Medication Industry Chain
  • 12.2 Emphysema Treatment Medication Upstream Analysis
  • 12.3 Emphysema Treatment Medication Midstream Analysis
  • 12.4 Emphysema Treatment Medication Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Emphysema Treatment Medication. Industry analysis & Market Report on Emphysema Treatment Medication is a syndicated market report, published as Global Emphysema Treatment Medication Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Emphysema Treatment Medication market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo